BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the 5-year period from 2007 to 2012. An assessment of the worldwide catheter market was performed while considering all of its important segments such as cardiovascular, urology, neurovascular, intravenous, and specialty catheters.

1. The Global Catheters Market
ReportsnReports.com adds BCC Research Market Research Report “The Global Catheters
Market’’ to its store.
BCC Research’s goal in conducting this study was to determine the present status of
the worldwide catheter market and to evaluate its potential over the 5-year period from
2007 to 2012. An assessment of the worldwide catheter market was performed while
considering all of its important segments such as cardiovascular, urology, neurovascular,
intravenous, and specialty catheters.
SCOPE OF STUDY
This report contains:
 Descriptions of catheter technologies and their potential applications
 The current global market status of catheters, trends, and forecasts for growth over the
next 5 years
 Technological issues, including the latest developments
 A discussion of regulatory issues affecting the current market and their potential impact
on future markets
 Profiles of major manufacturers/suppliers of catheter technologies.
METHODOLOGY
BCC Research presents an analysis of each segment of catheters depending on its
application, using a base year of 2007. Estimated values used are based on what
manufacturers have paid in non-depreciated dollars.
INFORMATION SOURCES
Both primary and secondary sources were used in this research. Major sources of primary
research information were numerous key players in this industry. Secondary research
sources include various Internet sources, company Web sites, financial and trade
information, and government sources.
ABOUT THE AUTHOR
Alpita Shah has an MBA in Healthcare and a B.S. in life sciences. She has published many
articles and reports in the areas of biotechnology and healthcare. She is familiar with the
operations of many healthcare companies.
Table of Contents
Chapter- 1: INTRODUCTION — Complimentary 3
STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THE STUDY 1

2. SCOPE OF REPORT 1
METHODOLOGY 1
INTENDED AUDIENCE 2
INFORMATION SOURCES 2
ANALYST CREDENTIALS 2
RELATED REPORTS 2
BCC ONLINE SERVICES 2
DISCLAIMER 3
Chapter-2: SUMMARY 3
SUMMARY 4
SUMMARY TABLE GLOBAL CATHETER MARKET, THROUGH 2014 ($ MILLIONS) 5
SUMMARY FIGURE GLOBAL CATHETER MARKET, 2008 AND 2014 (%) 6
Chapter-3: OVERVIEW OF GLOBAL CATHETER INDUSTRY 19
ORIGINS 7
CATHETER CONSTRUCTION 8
CATHETER APPLICATIONS 8
TYPES OF CATHETERS 9
CARDIOVASCULAR CATHETERS 9
Diagnostic Procedures and Cardiac Catheterization 10
TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 10
TABLE 1 (CONTINUED) 11
TABLE 2 TYPES OF CARDIAC CATHETERS 11
Angiography Catheters 11
Electrophysiology (EP) Catheters 12
Percutaneous Coronary Intervention (PCI) Catheters 13
TABLE 3 PTCA PROCEDURES 13
Rapid Exchange PTCA Balloon Catheters 14
Over – the-Wire PTCA Catheters 14
Guiding Catheter 14
UROLOGICAL CATHETERS 15
Types of Urinary Catheterizations 16
Intermittent Catheterization 16
Indwelling Catheterization 16
Suprapubic Catheterization 17
Male External Condom Catheters 18
NEUROVASCULAR CATHETERS 18
INTRAVENOUS (IV) CATHETERS 19
Single-Lumen Catheters 19
Multi-Lumen Catheter 20
Specialty IV Catheters 20
Peripheral Vein Catheter 20
Central Venous Catheter 20
Peripherally Inserted Central Catheters (PICCs) 21
TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 22
SPECIALTY CATHETERS 22
Thermodilution Catheters 22

3. Suction Catheters 23
Oximetry Catheters 23
END-USER PREFERENCES 24
SIZE OF CATHETER 24
MATERIAL USED 24
COATING 25
DURATION OF CATHETER IN THE BODY 25
INFECTION 25
COST 25
Chapter-4: CATHETERS AND WORLD DEMOGRAPHICS 4
TABLE 5 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2004 AND 2006*
(THOUSANDS) 26
WORLDWIDE PROCEDURES 27
TABLE 6 SELECTED WORLDWIDE CORONARY PROCEDURES, 2008 (PER 100,000
POPULATION) 27
WORLDWIDE ECONOMIC DEMOGRAPHICS 28
TABLE 7 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY,
1980 – 2005 (%) 28
TABLE 7 (CONTINUED) 29
WORLDWIDE POPULATION GROWTH 29
Chapter-5: CATHETER MATERIALS 7
KEY CHARACTERISTICS OF CATHETER MATERIALS 30
TABLE 8 CHARACTERISTICS OF CATHETER MATERIALS 30
SURFACE CHARACTERISTICS 31
RADIOPACITY 31
COMPONENT MATERIALS 31
LATEX 32
SILICONE 32
TEFLON (FLUOROPOLYMER) 33
POLYURETHANE 33
POLYVINYL CHLORIDE (PVC) 33
POLYETHYLENE 33
CATHETER COATINGS 34
SILICONE ELASTOMER 34
HYDROPHILIC COATING 34
ANTIMICROBIAL COATING 35
Silver Coating 35
ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 35
TABLE 9 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 36
Chapter-6: ANALYSIS OF THE GLOBAL CATHETER MARKET 26
FACTORS INFLUENCING MARKET GROWTH 37
FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 38
DEMOGRAPHICS 38

4. SURGICAL AND MEDICAL TRENDS 38
Catheter Reuse 39
REIMBURSEMENT 39
EMERGING TECHNOLOGY 39
PRODUCT DISTRIBUTION 40
PURCHASING TRENDS 40
TREATMENT COSTS 40
LEADING MANUFACTURERS 41
TABLE 10 REVENUES OF KEY CATHETER MANUFACTURERS, 2007 AND 2008 ($
MILLIONS) 41
KEY MARKET DRIVERS 41
INCREASE IN PROCEDURES HAS LED TO INCREASED DEMAND FOR CATHETERS 42
INCREASED DEMAND FOR DISPOSABLE CATHETERS DUE TO RISK OF INFECTION AND AIDS
42
NEW TECHNOLOGIES IN CATHETERS HAVE INCREASED CATHETER USE 42
INCREASE IN MINIMALLY INVASIVE PROCEDURES REQUIRING CATHETERS HAS INCREASED
SALES 42
ADVANCES IN IMAGING TECHNOLOGY HAS LED TO NEW APPLICATIONS REQUIRING THE
USE OF CATHETERS 43
KEY MARKET RESTRAINTS 43
PRICE EROSIONS DUE TO FIERCE COMPETITION ARE SHRINKING REVENUES 43
LONG FDA APPROVAL TIMES ARE RESULTING IN DELAYED LAUNCHES OF NEW PRODUCTS
43
REIMBURSEMENT ISSUES HAVE AFFECTED THE USE OF TECHNOLOGICALLY ADVANCED
CATHETERS 44
EXPERIENCED PHYSICIANS OFTEN ARE RELUCTANT TO ACCEPT NEW DEVICE
TECHNOLOGIES 44
GLOBAL CATHETER REVENUE ANALYSIS 44
TABLE 11 PROJECTED GLOBAL CATHETER MARKET BY SEGMENT, THROUGH 2014
($ MILLIONS 45
FIGURE 2 PROJECTED GLOBAL CATHETER MARKET, 2009 ($ MILLIONS) 45
FIGURE 2 (CONTINUED) 46
TABLE 12 PROJECTED GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2008
AND 2014 (%) 47
FIGURE 3 GLOBAL CATHETER MARKET SHARES BY SEGMENT, 2009 AND 2014 (%)
48
MARKET SHARE FORECAST 49
CONSEQUENCES OF THE 2008 ECONOMIC SLOWDOWN 49
REVENUES, SHARES, AND PROJECTIONS BY REGION 50
TABLE 13 PROJECTED GLOBAL CATHETER MARKET BY REGION, THROUGH 2014 ($
MILLIONS) 50
TABLE 14 PROJECTED GLOBAL CATHETER MARKET SHARES BY REGION, 2008 AND
2014 (%) 51
U.S. Catheter Market 51
European Catheter Market 52
Rest of the World Catheter Market 53
REPROCESSED CATHETERS 54
COMPETITIVE STRUCTURE 55
TYPES OF COMPETITION 56

5. TIERS OF COMPETITION 56
MERGERS AND ACQUISITIONS 56
TABLE 15 SELECTED KEY MERGERS AND ACQUISITIONS WITHIN THE CATHETER
MARKET, 2008-2009 ($) 57
END-USER GROUPS 57
DISTRIBUTION STRUCTURE 58
PURCHASE STRUCTURE 59
COMPETITIVE FACTORS 59
Regulatory Environment 59
Pricing 59
Catheter Properties 60
Branding 60
ANALYSIS OF THE GLOBAL CATHETER MARKET BASED ON STRENGTHS, OPPORTUNITIES,
WEAKNESSES, AND THREATS 60
STRENGTHS 60
OPPORTUNITIES 61
WEAKNESSES 61
THREATS 62
Chapter-7: CARDIOVASCULAR CATHETERS 11
KEY MARKET CHALLENGES 63
CONTROVERSY REGARDING THE USE OF DRUG-ELUTING STENTS AFFECTS CATHETER USE
63
PHARMACOLOGICAL APPROACHES ARE THREATENING CATHETER DEMAND 64
LACK OF CLINICAL DATA IS HINDERING ACCEPTANCE OF NEWER CATHETERS BY
PHYSICIANS 64
KEY MARKET DRIVERS 64
INCREASES IN THE INCIDENCE OF CARDIOVASCULAR DISEASES IS DRIVING THE NUMBER
OF PROCEDURES 64
POPULARITY OF ANGIOPLASTY AND STENTS OVER BYPASS SURGERY IS LEADING TO AN
INCREASE IN THE USE OF CARDIAC CATHETERS 65
ANGIOGRAPHY IS DRIVING THE INCREASE IN THE NUMBER OF DIAGNOSTIC PROCEDURES
65
INTERVENTIONAL CARDIAC PROCEDURES ARE MORE EFFECTIVE THAN PHARMACEUTICAL-
BASED THERAPIES 66
KEY MARKET RESTRAINTS 66
CONSTANT PRICE EROSION IS LEADING TO DECREASED REVENUES 66
DECREASE IN RESTENOSIS IS AFFECTING THE NUMBER OF STENT PROCEDURES
PERFORMED 66
CATHETER USAGE IS RESTRAINED DUE TO LOW REIMBURSEMENT RATES 67
CARDIOVASCULAR CATHETER MARKET ANALYSIS 67
TABLE 16 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE,
THROUGH 2014 ($ MILLIONS) 67
FIGURE 4 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE,
2014 ($ BILLIONS) 68
ANGIOGRAPHY 69
ELECTROPHYSIOLOGY/MAPPING CATHETERS 69
BALLOON CATHETERS 69

6. GUIDING CATHETERS 70
INTRAVASCULAR ULTRASOUND CATHETERS 70
TABLE 17 PROJECTED GLOBAL CARDIOVASCULAR CATHETER MARKET BY TYPE OF
PROCEDURE, 2009 AND 2014 (%) 70
FIGURE 5 GLOBAL CARDIOVASCULAR CATHETER SHARES BY REGION, 2009 AND
2014 (%) 71
MARKET SHARES BY COMPANY 72
TABLE 18 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY,
2008 (%) 72
FIGURE 6 GLOBAL CARDIOVASCULAR CATHETER MARKET SHARES BY COMPANY,
2008 (%) 72
CARDIOVASCULAR CATHETER PRODUCTS BY COMPANY 73
COMPETITIVE STRUCTURE 73
Chapter-8: UROLOGY CATHETER MARKET 8
KEY MARKET CHALLENGES 74
USE OF LONG-TERM CATHETERS IS THREATENING THE GROWTH OF DISPOSABLE
CATHETERS 74
USE OF CATHETERS HAS DECLINED DUE TO AN INCREASE IN THE NUMBER OF URINARY
TRACT INFECTIONS (UTI) 74
SOME PHYSICIANS ARE NOT READY TO ACCEPT NEW PRODUCTS DUE TO A LACK OF
CLINICAL DATA 75
KEY MARKET DRIVERS 75
INCREASE IN UROLOGY PROCEDURES IS LEADING TO INCREASED CATHETER USE 75
CATHETERS WITH ANTIMICROBIAL COATINGS ARE INCREASING CONFIDENCE IN THE USE
OF CATHETERS 75
SOME PRODUCTS CAN BE USED BY PATIENTS THEMSELVES, INCREASING PATIENT
ADOPTION 76
KEY MARKET RESTRAINTS 76
LENGTHY FDA APPROVAL TIMES HAVE LED TO DELAYS IN THE LAUNCH OF EFFECTIVE
ANTIMICROBIAL CATHETERS 76
OCCURRENCES OF UTI IS DISCOURAGING CATHETER USAGE 76
UROLOGY CATHETER MARKET ANALYSIS 76
TABLE 19 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, THROUGH
2014 ($ MILLIONS) 77
FIGURE 7 PROJECTED GLOBAL UROLOGY CATHETER MARKET BY TYPE, 2008-2014
($ MILLIONS) 78
MARKET SHARES AND PROJECTIONS BY TYPE OF CATHETER 78
TABLE 20 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE,
2008 AND 2014 (%) 79
FIGURE 8 PROJECTED GLOBAL UROLOGY CATHETER MARKET SHARES BY TYPE,
2014 (%) 79
Intermittent Catheters 79
Foley Catheters 80
Other Catheters 80
MARKET SHARES BY COMPANY 80
TABLE 21 GLOBAL UROLOGY CATHETER MARKET SHARES BY COMPANY, 2008 (%)
81

7. UROLOGY CATHETER PRODUCTS BY COMPANY 81
COMPETITIVE STRUCTURE 81
Chapter-9: NEUROVASCULAR CATHETER MARKET 5
KEY MARKET CHALLENGES 82
COST OF SPECIALIZED MICROCATHETERS AFFECTS THEIR ADOPTION 82
KEY MARKET DRIVERS 82
ADVANCES IN IMAGING TECHNOLOGIES ARE CREATING NEW AREAS OF DIAGNOSIS AND
TREATMENT 82
STENTING AND ANEURYSM TREATMENTS ARE INCREASING CATHETER USE 82
NEW CATHETER TECHNOLOGIES ARE IMPROVING PROCEDURES AND INCREASING DEMAND
83
MARKET POTENTIAL EXISTS IN UNMET TREATMENT OPTIONS 83
KEY MARKET RESTRAINTS 83
INCREASED AVAILABILITY OF PHARMACOLOGICAL TREATMENT OPTIONS IS INHIBITING
NEUROCATHETER USE 83
SHORTAGE OF PROFESSIONALS QUALIFIED TO PERFORM INVASIVE NEUROLOGICAL
PROCEDURES IS INFLUENCING NEUROCATHETER SALES 84
MANY PATIENTS DIE BEFORE RECEIVING TREATMENT 84
NEUROVASCULAR CATHETER MARKET ANALYSIS 84
TABLE 22 PROJECTED GLOBAL NEUROVASCULAR CATHETER MARKET, THROUGH
2014 ($ MILLIONS) 85
MARKET SHARES BY COMPANY 85
TABLE 23 GLOBAL NEUROVASCULAR CATHETER MARKET SHARES BY COMPANY,
2008 (%) 86
NEUROVASCULAR PRODUCTS, BY COMPANY 86
COMPETITIVE STRUCTURE 86
Chapter-10: INTRAVENOUS CATHETER MARKET 6
KEY MARKET CHALLENGES 87
LACK OF CLINICAL DATA CHALLENGES ADOPTION OF NEW IV CATHETERS 87
MANUFACTURERS FACE PRICE EROSION AND FIERCE COMPETITION 87
KEY MARKET DRIVERS 88
STRICT CATHETER REPLACEMENT RULES ARE INCREASING SALES 88
IV CATHETERS WITH ANTIMICROBIAL COATINGS IMPROVE THEIR MARKETABILITY 88
INCREASED APPLICATIONS AND INTRODUCTION OF NEW TECHNOLOGY BOOSTS IV
CATHETER SALES 88
KEY MARKET RESTRAINTS 89
CONSTANT PRICE EROSION IS LEADING REVENUE LOSSES 89
REIMBURSEMENT ISSUES REDUCE THE USE OF HIGH-END IV CATHETERS 89
INTRAVENOUS CATHETER MARKET ANALYSIS 89
TABLE 24 PROJECTED GLOBAL IV CATHETER MARKET BY TYPE, THROUGH 2014 ($
MILLIONS) 89
FIGURE 9 PROJECTED GLOBAL IV CATHETER MARKET, 2008-2014 ($ MILLIONS) 90
MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 90
TABLE 25 PROJECTED GLOBAL INTRAVENOUS CATHETER SHARES BY TYPE, 2008
AND 2014 (%) 91
MARKET SHARES BY COMPANY 91

8. TABLE 26 GLOBAL INTRAVENOUS CATHETER MARKET SHARES BY COMPANY, 2008
(%) 92
IV CATHETER PRODUCTS BY COMPANY 92
COMPETITIVE STRUCTURE 92
Chapter-11: SPECIALTY CATHETERS 5
KEY MARKET CHALLENGES 93
LACK OF CLINICAL DATA TO SUPPORT EFFICACY 93
KEY MARKET DRIVERS 93
DEMAND FOR ENHANCED MONITORING DEVICES IS LEADING TO MORE SALES 93
THE EFFECTIVENESS OF SPECIALTY CATHETERS IS FUELING INTEREST BY MEDICAL STAFF
AND PROMOTING THEIR USE 93
KEY MARKET RESTRAINTS 94
HIGH PRICE OF CATHETERS INHIBITS SALES 94
LIMITED INTERNATIONAL EXPANSION DUE TO THE HIGHER COST OF SPECIALTY
CATHETERS 94
SPECIALTY CATHETER MARKET ANALYSIS 94
TABLE 27 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, THROUGH
2014 ($ MILLIONS) 94
FIGURE 10 PROJECTED GLOBAL SPECIALTY CATHETER MARKET BY TYPE, 2008-
2014 ($ MILLIONS) 95
MARKET SHARES AND PROJECTIONS BY CATHETER TYPE 95
TABLE 28 PROJECTED GLOBAL SPECIALTY CATHETER MARKET SHARES BY TYPE,
2008 AND 2014 (%) 96
MARKET SHARES BY COMPANY 96
TABLE 29 SPECIALTY CATHETER MARKET SHARES BY COMPANY, 2008 (%) 97
SPECIALTY PRODUCTS BY COMPANY 97
COMPETITIVE STRUCTURE 97
Chapter-12: GOVERNMENT REGULATIONS AND ISSUES 18
CATHETER MARKET REGULATIONS 98
CLASS I MEDICAL DEVICES 98
CLASS II 98
CLASS III 98
TABLE 30 CATHETER TYPES AND CLASS 99
TABLE 30 (CONTINUED) 100
TABLE 30 (CONTINUED) 101
FDA APPROVAL PROCESS 101
PREMARKET NOTIFICATION 510(K) 102
PREMARKET APPROVAL (PMA) 103
INVESTIGATIONAL DEVICE EXEMPTION (IDE) 104
ESTABLISHMENT REGISTRATION FORM 105
MEDICAL DEVICE LISTING 105
QUALITY SYSTEM (QS) REGULATION 106
LABELING 107
MEDICAL DEVICE REPORTING 107
EUROPEAN HEALTHCARE STANDARDS 107
REGULATORY DIRECTIVES 108
The Active Implantable Medical Device Directive (AIMD) [90/385/EEC] 108

9. The Medical Device Directive (MDD) [93/42/EEC] 108
The In Vitro Medical Devices Directive (IVD) [98/79/EC] 108
JAPANESE STANDARDS 109
CHINESE STANDARDS 109
INTERNATIONAL ORGANIZATION FOR STANDARDS (ISO) 110
TABLE 31 CATHETER ISO NUMBERS 110
DIFFERENCES IN EUROPEAN AND U.S. REGULATIONS 110
RECENT FDA 510(K) APPROVALS, EUROPEAN UNION CE APPROVALS, JAPANESE
APPROVALS. 111
TABLE 32 SELECTED U.S. FDA 510(K) APPROVALS, CE MARK APPROVAL, AND
JAPANESE APPROVAL OF CATHETERS, 2007 – 2009 111
TABLE 32 (CONTINUED) 112
TABLE 32 (CONTINUED) 113
FDA RECALLS 113
MISLABELING 113
NONSTERILE CONDITIONS 114
MANUFACTURING DEFECTS/MALFUNCTIONS 114
TABLE 33 U.S. CATHETER RECALLS IN 2008, 2009 114
TABLE 33 (CONTINUED) 115
Chapter-13: PATENT ANALYSIS 11
GLOBAL PATENT APPLICATIONS, 2008 AND 2009 116
TABLE 34 GLOBAL CATHETER PATENT APPLICATIONS, 2008-2009 117
CATHETER PATENT ACTIVITY BY ASSIGNEE 117
TABLE 35 CATHETER PATENT APPLICATION ACTIVITY BY ASSIGNEE, JANUARY
2007-JUNE 2009 (NUMBER OF PATENTS) 117
TABLE 35 (CONTINUED) 118
GLOBALLY ISSUED PATENTS, BY SEGMENT 118
TABLE 36 GLOBAL PATENTS ISSUED, BY SEGMENT, 2008-2009 118
TABLE 37 ISSUED CATHETER PATENT SHARES, BY SEGMENT, JANUARY 2007-JUNE
2009 (%) 119
FIGURE 11 SHARE FOR ISSUED CATHETER PATENTS, BY SEGMENT, JANUARY 2007-
JUNE 2009 (%) 119
CARDIOVASCULAR CATHETER PATENTS 120
TABLE 38 ISSUED CARDIOVASCULAR CATHETER PATENTS BY TYPE, MAY 2007-MAY
2009 120
FIGURE 12 ISSUED CARDIOVASCULAR CATHETER PATENTS, BY TYPE, MAY 2007-
MAY 2009 (%) 120
UROLOGY CATHETER PATENTS 121
TABLE 39 ISSUED UROLOGY CATHETER PATENTS BY TYPE, JANUARY 2007-JUNE
2009 121
IV CATHETER PATENTS 121
TABLE 40 ISSUED IV CATHETER PATENTS BY TYPE, MAY 2007-MAY 2009 122
SPECIALTY CATHETER PATENTS 122
NEUROVASCULAR 122
MAJOR CATHETER PATENT RECIPIENTS FROM 1999 TO MAY 2009 122
TABLE 41 U.S. CATHETER PATENT NUMBERS BY ASSIGNEE, 1999-MAY 2009 122
TABLE 41 (CONTINUED) 123
TABLE 41 (CONTINUED) 124

10. FIGURE 13 PERCENT OF CATHETER PATENTS ISSUED TO TOP 10 MANUFACTURERS,
1999-MAY 2009 (%) 124
FIGURE 13 (CONTINUED) 125
CATHETER PATENT ACTIVITY BY COUNTRY 125
TABLE 42 CATHETER PATENT ACTIVITY BY COUNTRY, JANUARY 2008-JUNE 2009
(NUMBER OF PATENTS FILED) 125
TABLE 42 (CONTINUED) 126
CONCLUSIONS OF THE PATENT ANALYSIS 126
Chapter-14: COMPANY PROFILES 39
ABBOTT LABORATORIES 127
TABLE 43 ABBOTT LABORATORIES’ CATHETER PRODUCTS 127
TABLE 43 (CONTINUED) 128
ANGIODYNAMICS 128
TABLE 44 ANGIODYNAMICS CATHETER PRODUCTS 129
ARROW INTERNATIONAL (SEE TELEFLEX) 129
ASTRA TECH, INC.-UROLOGY DIVISION 129
TABLE 45 ASTRA TECH CATHETER PRODUCTS 130
B BRAUN MELSUNGEN AG 130
TABLE 46 B BRAUN CATHETER PRODUCTS 131
BECTON DICKINSON & CO. 131
TABLE 47 BD CATHETER PRODUCTS 132
BOSTON SCIENTIFIC 132
TABLE 48 BOSTON SCIENTIFIC CATHETER PRODUCTS 133
TABLE 48 (CONTINUED) 134
CARDINAL HEALTH 134
TABLE 49 CARDINAL HEALTH CATHETER PRODUCTS 135
COLOPLAST GROUP 135
TABLE 50 COLOPLAST CATHETER PRODUCTS 136
COOK MEDICAL 136
TABLE 51 COOK MEDICAL CATHETER PRODUCTS 137
TABLE 51 (CONTINUED) 138
COVIDIEN (FORMERLY TYCO HEALTHCARE) 138
TABLE 52 COVIDIEN CATHETER PRODUCTS 138
TABLE 52 (CONTINUED) 139
CR BARD 139
TABLE 53 CR BARD CATHETER PRODUCTS 140
TABLE 53 (CONTINUED) 141
EDWARDS LIFESCIENCES 141
TABLE 54 EDWARDS LIFESCIENCES CATHETER PRODUCTS 142
EV3 ENDOVASCULAR, INC. 143
TABLE 55 EV3 CATHETER PRODUCTS 143
HOLLISTER 144
TABLE 56 HOLLISTER CATHETER PRODUCTS 144
HOSPIRA, INC. 144
TABLE 57 HOSPIRA CATHETER PRODUCTS 145
IRVINE BIOMEDICAL, INC. (SEE ST. JUDE MEDICAL) 145
JOHNSON & JOHNSON 145
TABLE 58 JOHNSON & JOHNSON CATHETER PRODUCTS 146

11. TABLE 58 (CONTINUED) 147
MEDTRONIC, INC. 147
TABLE 59 MEDTRONIC CATHETER PRODUCTS 148
MERIT MEDICAL SYSTEMS 148
TABLE 60 MERIT MEDICAL CATHETER PRODUCTS 149
ROCHESTER MEDICAL 149
TABLE 61 ROCHESTER MEDICAL CATHETER PRODUCTS 150
SMITHS MEDICAL 150
TABLE 62 SMITHS MEDICAL CATHETER PRODUCTS 151
TABLE 62 (CONTINUED) 152
ST. JUDE MEDICAL 152
TABLE 63 ST. JUDE MEDICAL CATHETER PRODUCTS 153
TELEFLEX MEDICAL (FORMERLY ARROW INTERNATIONAL) 153
TABLE 64 ARROW/TELEFLEX MEDICAL CATHETER PRODUCTS 154
TABLE 64 (CONTINUED) 155
TERUMO MEDICAL CORP. 155
TABLE 65 TERUMO CORP. CATHETER PRODUCTS 156
TABLE 65 (CONTINUED) 157
TYCO HEALTHCARE (SEE COVIDIEN) 157
VASCULAR SOLUTIONS 157
TABLE 66 VASCULAR SOLUTIONS CATHETER PRODUCTS 157
APPENDIX: CATHETER PRODUCTS AND THEIR MANUFACTURERS 158
TABLE 67 CATHETER PRODUCTS AND MANUFACTURERS 158
TABLE 67 (CONTINUED) 159
TABLE 67 (CONTINUED) 160
TABLE 67 (CONTINUED) 161
TABLE 67 (CONTINUED) 162
TABLE 67 (CONTINUED) 163
TABLE 67 (CONTINUED) 164
TABLE 67 (CONTINUED) 165
Latest Market Research Reports:
 LIver Disease Treatments: The Global Market
 Merchant Hydrogen Generation and On-site Distributed Generation
 Global Markets for Flame Retardant Chemicals and Plastics
 DNA Sequencing: Emerging Technologies and Applications
 2011 Fuel Cell Industry Review
 2011 Hybrid & Electric Vehicle Progree Review
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

12. Contact:
Mr. Priyank
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit Our Blog: Market Research Reports